The National Pharmaceutical Pricing Authority (NPPA) on June 03, 2024, issued the notification regarding the Retail Price Calculation of each film-coated bilayered tablet containing Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 2mg + Metformin Hydrochloride IP 1000mg.
The following has been stated namely: -
• Retail Price has been calculated of each film-coated bilayered tablet containing: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10mg + Glimepiride IP 2mg + Metformin Hydrochloride IP 1000mg (as Extended release) for M/s Mascot Health Series Pvt Ltd. (Manufacturer) & M/s Intas Pharmaceuticals Ltd (Marketer) (Fl No 4025)
• The Date of Application was May 20, 2024
• The proposed price {lower of E7F (option I and II)} is 15.31
• The price computation is based on data from October 2023
[Notification No. 19(4025)/2024/DP/NPPA/Div.II]
